首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Quantification of eight benzodiazepines in human breastmilk and plasma by liquid-liquid extraction and liquid-chromatography tandem mass spectrometry: Application to evaluation of alprazolam transfer into breastmilk
【24h】

Quantification of eight benzodiazepines in human breastmilk and plasma by liquid-liquid extraction and liquid-chromatography tandem mass spectrometry: Application to evaluation of alprazolam transfer into breastmilk

机译:液液萃取和液相色谱串联质谱法定量人母乳和血浆中的八苯二氮卓类药物:应用于评估芦荟醛转移到母乳中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Breastfeeding is strongly encouraged for infant and maternal health. Benzodiazepines (BZDs) are widely prescribed drugs for symptoms, such as anxiety and insomnia, which many women could experience during the postpartum period. However, limited information is currently available to evaluate the transfer of different BZDs into breastmilk. In order to assess the proprieties of this medication during breastfeeding, robust and sensitive analytical methods to quantify BZDs are required. For this purpose, we developed a method for quantification of BZDs, including alprazolam, bromazepam, clonazepam, clotiazepam, etizolam, flunitrazepam, lorazepam, and CM7116 (a metabolite of ethyl loflazepate), in human breastmilk and plasma using liquid chromatography/tandem mass spectrometry (LC/MS/MS). Sample preparation was performed by a simple liquid-liquid extraction (LLE) with ethyl acetate. For sample preparation of CM7116, the pretreatment process to completely obtain the metabolite was added before the LLE step. The BZDs were separated by a C-18 column using a gradient elution of acetonitrile in aqueous ammonium acetate solution, and were detected in the positive ion electrospray mode with multiple reaction monitoring (MRM). Lower limits of quantification (LLOQs) in breastmilk ranged from 0.25 to 0.5 ng/mL, and those in plasma ranged from 0.5 to 1.0 ng/mL. The intra-day and inter-day precision, and accuracy of data were assessed and found to be acceptable. The developed method was successfully applied to measure the concentration of alprazolam in breastmilk and plasma, which were donated by a lactating woman who had been regularly treated with alprazolam. Milk to plasma (M/P) ratios were calculated as 0.52 (before oral administration) and 0.49 (2 h after administration) 3 days after delivery. The M/P ratio 1 month after delivery was calculated as 0.41 (2 h after administration). We estimated that the relative infant dose (RID) values of alprazolam ranged from 3.11 to 4.61%. (C) 2019 Elsevier B.V. All rights reserved.
机译:婴儿和产妇健康强烈鼓励母乳喂养。苯二氮卓类药物(BZDS)是广泛的症状药物,如焦虑和失眠,许多女性在产后期间可能会经历。但是,目前可以使用有限的信息来评估将不同BZDS转移到母乳中的转移。为了在母乳喂养期间评估该药物的所有药物,需要稳健和敏感的分析方法来量化BZD。为此目的,我们开发了一种用于量化BZD的方法,包括Alprazolam,Bromazepam,Clonazepam,Clotiazepam,Etizolam,Flunitrazepam,Lorazepam和Cm7116(乙基洛哌齐酸代谢物),使用液相色谱/串联质谱法在人母乳中和血浆中(LC / MS / MS)。通过用乙酸乙酯的简单的液 - 液萃取(LLE)进行样品制剂。对于CM7116的样品制备,在LLE步骤之前加入预处理方法以完全获得代谢物。通过乙酸铵水溶液中的乙腈梯度洗脱,通过C-18柱分离BZDS,并在正离子电喷雾模式下检测多重反应监测(MRM)。母乳中的量化限制(LLOQ)的限制范围为0.25至0.5ng / ml,等离子体中的血浆中的量为0.5至1.0ng / ml。评估日内和日间间精度,以及数据的准确性,并发现是可接受的。成功地应用了开发的方法,以测量母乳碱和血浆中阿普拉唑仑的浓度,这些血浆被哺乳酸的妇女捐赠,他们经常用alprazolam治疗。递送后3天,将牛奶与血浆(M / P)比率计算为0.52(口服给药前)和0.49(施用后2小时)。递送后1个月的M / P比计算为0.41(给药后2小时)。我们估计,Alprazolam的相对婴儿剂量(RiT)值范围为3.11至4.61%。 (c)2019 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号